Literature DB >> 6704790

Etiology of Parkinson's disease: A research strategy.

A Barbeau.   

Abstract

In this essay I present a new "global approach hypothesis" to explain the pathophysiology of Parkinson's disease: "Susceptibility to Parkinsonism is genetically determined and is reflected in all cells. I propose that idiopathic Parkinson's disease is the combined result of a generalized cell aging process accelerated, in susceptible individuals, by a variety of often repetitive trigger factors. These factors have in common the fact that they cause a transient increase in turnover within catecholamine producing neurons, centrally as well as peripherally. This results in accumulation within these neurons of free radicals. When the level of the toxic substances, in quantity or in time of exposure, exceeds the scavenging capacity of the cell, damage to organelles and to membranes results, leading to the formation of Lewy bodies through an autoimmune reaction to damaged filaments and to cell death, particularly in the pigmented neurons of the brainstem. The progressive cell depletion leads to a compensatory increase in catecholamine turnover in the remaining pigmented cells, and an ever-accelerating degenerative process. The resulting neurotransmitter imbalance in the basal ganglia explains the symptoms of Parkinson's disease". In the light of this hypothesis, our research objectives should be (1) to delineate the limits of true Parkinson's disease from all phenocopies; (2) to identify individuals susceptible to parkinsonism and the most common trigger factors; (3) to reduce the metabolic effects of unavoidable trigger factors and (4) to protect susceptible individuals by increasing the functional availability of free radical trapping agents.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704790     DOI: 10.1017/s0317167100045273

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  9 in total

1.  Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease.

Authors:  J Kalra; A H Rajput; S V Mantha; A K Chaudhary; K Prasad
Journal:  Mol Cell Biochem       Date:  1992-06-26       Impact factor: 3.396

Review 2.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

3.  Glutathione peroxidase in early and advanced Parkinson's disease.

Authors:  P Johannsen; G Velander; J Mai; E B Thorling; E Dupont
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

4.  Determinants of autonomic dysfunction in idiopathic Parkinson's disease.

Authors:  Alexei Korchounov; Kirn R Kessler; Nikolay N Yakhno; Igor V Damulin; Hayo I Schipper
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

5.  Movement disorder associated with abnormal copper metabolism and decreased blood antioxidants.

Authors:  H S Pall; A C Williams; D R Blake; P Winyard; S Chirico; S Brailsford
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

Review 6.  Parkinson's disease in 1984: an update.

Authors:  A E Lang; R D Blair
Journal:  Can Med Assoc J       Date:  1984-11-01       Impact factor: 8.262

Review 7.  Methylcyclopentadienyl manganese tricarbonyl: health risk uncertainties and research directions.

Authors:  J M Davis
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 8.  Aging and Parkinson's disease: Different sides of the same coin?

Authors:  Timothy J Collier; Nicholas M Kanaan; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2017-05-18       Impact factor: 10.338

9.  Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos.

Authors:  Mourad Tayebi; Charles M El-Hage; Pedro Pinczowski; Pam Whiteley; Monique David; Qiao-Xin Li; Shiji Varghese; Meena Mikhael; Umma Habiba; David Harman; Liliana Tatarczuch; Mirjana Bogeski; Ian Birchall; Kirsty Ferguson; Larry Walker; Colin Masters; Brian A Summers
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.